Use of neboglamine in the treatment of toxicodependency

US8258185B2 · kind B2 · utility

Assignee

• Rottapharm SpA · IT

Inventors

• Francesco Makovec · Monza, IT
• Gianfranco Caselli · L'Aquila, IT
• Lucio Claudio Rovati · Monza, IT
• Antonio Giordani · Pavia, IT

Key dates

• Filing date: Jul 27, 2011
• Grant date: Sep 4, 2012
• Expiry date: Jul 27, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/36
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of neboglamine, (S)-4-amino-N(4,4-dimethyl-cyclohexyl)glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), the racemic mixture thereof or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the treatment of toxicodependency induced by drugs such as CNS sedatives such as opiates, barbiturates, benzodiazepines, alcohol, stimulants such as amphetamines and cocaine, and hallucinogens such as LSD, mescalin, cannabis (marijuana) or fencyclidine.